JP2012131827A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012131827A5 JP2012131827A5 JP2012077545A JP2012077545A JP2012131827A5 JP 2012131827 A5 JP2012131827 A5 JP 2012131827A5 JP 2012077545 A JP2012077545 A JP 2012077545A JP 2012077545 A JP2012077545 A JP 2012077545A JP 2012131827 A5 JP2012131827 A5 JP 2012131827A5
- Authority
- JP
- Japan
- Prior art keywords
- weight
- amount
- composition
- desoxyascomycin
- epi
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Claims (5)
- 33−エピ−クロロ−33−デスオキシアスコマイシンを懸濁液中に含む、皮膚に投与するための局所用医薬組成物であって、
a)5重量%までの量の33−エピ−クロロ−33−デスオキシアスコマイシン、
b)20重量%までの量の濃厚剤、
c)40重量%までの量の親水性成分、
d)全量5重量%までの量の1個またはそれ以上の有機酸、
e)全量5重量%までの量の1個またはそれ以上の安定化剤、
f)90重量%までの量の水
を含む水中油型乳剤ゲルの形である、組成物。 - 懸濁液が、直径5から90ミクロンの33−エピ−クロロ−33−デスオキシアスコマイシンの粒子を含む、請求項1に記載の組成物。
- 濃厚剤が、パラフィン、蝋またはワセリンを含む、請求項1または2に記載の組成物。
- 親水性成分が、プロピレングリコール、セチルアルコール、ステアリルアルコールまたはオレイルアルコールを含む、請求項1〜3のいずれかに記載の組成物。
- 有機酸が、ソルビン酸を含む、請求項1〜4のいずれかに記載の組成物。
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9421612A GB9421612D0 (en) | 1994-10-26 | 1994-10-26 | Organic compounds |
GB9421612.4 | 1994-10-26 | ||
GB9422306A GB9422306D0 (en) | 1994-11-04 | 1994-11-04 | Organic compounds |
GB9422306.2 | 1994-11-04 | ||
GB9503553.1 | 1995-02-22 | ||
GBGB9503553.1A GB9503553D0 (en) | 1995-02-22 | 1995-02-22 | Organic compounds |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2007047216A Division JP2007145860A (ja) | 1994-10-26 | 2007-02-27 | 医薬組成物 |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2012131827A JP2012131827A (ja) | 2012-07-12 |
JP2012131827A5 true JP2012131827A5 (ja) | 2013-05-30 |
JP5599422B2 JP5599422B2 (ja) | 2014-10-01 |
Family
ID=27267447
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP51431096A Expired - Lifetime JP4155593B2 (ja) | 1994-10-26 | 1995-10-26 | 医薬組成物 |
JP2007047216A Withdrawn JP2007145860A (ja) | 1994-10-26 | 2007-02-27 | 医薬組成物 |
JP2012077545A Expired - Lifetime JP5599422B2 (ja) | 1994-10-26 | 2012-03-29 | 医薬組成物 |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP51431096A Expired - Lifetime JP4155593B2 (ja) | 1994-10-26 | 1995-10-26 | 医薬組成物 |
JP2007047216A Withdrawn JP2007145860A (ja) | 1994-10-26 | 2007-02-27 | 医薬組成物 |
Country Status (26)
Country | Link |
---|---|
US (1) | US6352998B2 (ja) |
EP (2) | EP0786986B1 (ja) |
JP (3) | JP4155593B2 (ja) |
KR (1) | KR100434682B1 (ja) |
CN (2) | CN1089233C (ja) |
AT (2) | ATE214593T1 (ja) |
AU (1) | AU714254B2 (ja) |
BR (1) | BR9509530A (ja) |
CA (1) | CA2200966C (ja) |
CY (1) | CY2211B1 (ja) |
CZ (1) | CZ289773B6 (ja) |
DE (3) | DE69525957T2 (ja) |
DK (2) | DK1147766T3 (ja) |
ES (2) | ES2243369T3 (ja) |
FI (2) | FI119754B (ja) |
GB (1) | GB2308546B (ja) |
HK (1) | HK1053611A1 (ja) |
HU (1) | HU223840B1 (ja) |
MX (1) | MX9702699A (ja) |
NO (2) | NO316963B1 (ja) |
NZ (2) | NZ295170A (ja) |
PL (1) | PL184750B1 (ja) |
PT (2) | PT786986E (ja) |
SI (1) | SI0786986T1 (ja) |
SK (1) | SK284591B6 (ja) |
WO (1) | WO1996013249A1 (ja) |
Families Citing this family (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR004480A1 (es) * | 1995-04-06 | 1998-12-16 | Amico Derin C D | Compuestos de ascomicina que poseen actividad antiinflamatoria, pro cedimiento para prepararlos, uso de dichos compuestos para preparar agentesfarmaceuticos y composiciones farmaceuticas que los incluyen |
GB9601120D0 (en) * | 1996-01-19 | 1996-03-20 | Sandoz Ltd | Organic compounds |
CZ283516B6 (cs) * | 1996-09-12 | 1998-04-15 | Galena A.S. | Léčivé přípravky, zejména pro vnitřní aplikaci, ve formě samomikroemulgujících terapeutických systémů |
US6495579B1 (en) * | 1996-12-02 | 2002-12-17 | Angiotech Pharmaceuticals, Inc. | Method for treating multiple sclerosis |
TW450810B (en) * | 1997-02-20 | 2001-08-21 | Fujisawa Pharmaceutical Co | Macrolides antibiotic pharmaceutical composition for preventing and treating skin diseases |
DE19744621A1 (de) * | 1997-10-09 | 1999-04-15 | Muehlbauer Ernst Kg | Mischung zur Verwendung als Wundverband |
GB9723669D0 (en) * | 1997-11-07 | 1998-01-07 | Univ Aberdeen | Skin penetration enhancing components |
DE19802205A1 (de) * | 1998-01-22 | 1999-07-29 | Beiersdorf Ag | Kosmetische und dermatologische Zubereitungen, enthaltend erhöhte Elektrolytkonzentrationen |
ID25908A (id) * | 1998-03-06 | 2000-11-09 | Novartis Ag | Prakonsentrat-prakonsentrat emulsi yang mengandung siklosporin atau makrolida |
CA2326222C (en) | 1998-04-27 | 2008-09-23 | Fujisawa Pharmaceutical Co., Ltd. | Medicinal compositions |
GB9814640D0 (en) * | 1998-07-06 | 1998-09-02 | Fujisawa Pharmaceutical Co | New use |
GB9826656D0 (en) * | 1998-12-03 | 1999-01-27 | Novartis Ag | Organic compounds |
US20070032853A1 (en) | 2002-03-27 | 2007-02-08 | Hossainy Syed F | 40-O-(2-hydroxy)ethyl-rapamycin coated stent |
GB0003932D0 (en) * | 2000-02-18 | 2000-04-12 | Novartis Ag | Pharmaceutical compositions |
WO2002065947A2 (de) * | 2001-02-16 | 2002-08-29 | Abbott Laboratories Vascular Enterprises Limited | Implante mit fk506 zur restenosebehandlung und -prophylaxe |
GB0108498D0 (en) * | 2001-04-04 | 2001-05-23 | Novartis Ag | Organic Compounds |
TWI324925B (en) * | 2001-08-23 | 2010-05-21 | Novartis Ag | Ophthalmic composition |
AR038628A1 (es) * | 2002-03-04 | 2005-01-19 | Novartis Ag | Composicion oftalmica |
GB0218996D0 (en) * | 2002-08-14 | 2002-09-25 | Novartis Ag | Organic compounds |
US20060115522A1 (en) * | 2003-02-17 | 2006-06-01 | Cipla Ltd | Pharmaceutical composition |
GB0307867D0 (en) * | 2003-04-04 | 2003-05-14 | Novartis Ag | Pharmaceutical composition |
GB0307866D0 (en) * | 2003-04-04 | 2003-05-14 | Novartis Ag | Pharmaceutical composition |
GB0307869D0 (en) * | 2003-04-04 | 2003-05-14 | Novartis Ag | Pharmaceutical composition |
AU2004258745A1 (en) * | 2003-07-31 | 2005-02-03 | Pharmacia & Upjohn Company Llc | Dispersible formulation of an anti-inflammatory agent |
RU2375044C2 (ru) * | 2004-04-08 | 2009-12-10 | Новартис Аг | Пимекролимусная пенная композиция, включающая гексиленгликоль, необязательно олеиловый спирт, диметилизосорбид и/или триглицериды со средними цепями |
GB0408070D0 (en) * | 2004-04-08 | 2004-05-12 | Novartis Ag | Pharmaceutical formulations |
GB0508827D0 (en) * | 2005-04-29 | 2005-06-08 | Novartis Ag | Cosmeceutical composition |
WO2008063563A2 (en) | 2006-11-16 | 2008-05-29 | Transderm, Inc. | Methods of treating keratin hyperproliferation disorders using mtor inhibitors |
EP2016935A1 (en) * | 2007-07-09 | 2009-01-21 | Intendis GmbH | Pharmaceutical composition for topical application of poorly soluble compounds |
CN101288643B (zh) * | 2008-06-17 | 2012-11-14 | 杨喜鸿 | 含有他克莫司的凝胶剂组合物及其制备方法和药物应用 |
EP2308468A1 (en) * | 2009-10-08 | 2011-04-13 | Novaliq GmbH | Novel pharmaceutical composition comprising a macrolide immunosuppressant drug |
GB0917816D0 (en) | 2009-10-12 | 2009-11-25 | Biotica Tech Ltd | Novel compounds and methods for their production |
GB0917817D0 (en) | 2009-10-12 | 2009-11-25 | Biotica Tech Ltd | Novel compounds and methods for their production |
EP2366378A1 (en) | 2010-03-01 | 2011-09-21 | Dexcel Pharma Technologies Ltd. | Sustained-release donepezil formulations |
JP5674786B2 (ja) * | 2010-07-23 | 2015-02-25 | マルホ株式会社 | タクロリムスを含有する水中油型クリーム状組成物 |
WO2012011192A1 (ja) * | 2010-07-23 | 2012-01-26 | マルホ株式会社 | タクロリムスを含有する水中油型クリーム状組成物 |
CN102552253A (zh) * | 2012-01-17 | 2012-07-11 | 唯美度科技(北京)有限公司 | 一种祛痘用皮肤外用剂 |
WO2013111817A1 (ja) * | 2012-01-25 | 2013-08-01 | マルホ株式会社 | タクロリムスを含有する水中油型クリーム状組成物 |
EP2948134B1 (en) * | 2013-01-24 | 2020-03-04 | Palvella Therapeutics, Inc. | Compositions for transdermal delivery of mtor inhibitors |
MX367121B (es) * | 2013-08-02 | 2019-08-06 | Laboratorio Raam De Sahuayo S A De C V | Composición sólida estable de inmunosupresores. |
DE102013222164A1 (de) * | 2013-10-31 | 2015-04-30 | Deb Ip Limited | Stabilisierte multiple Emulsionen als Hautschutzprodukt |
US10765665B2 (en) * | 2015-11-24 | 2020-09-08 | Melin Jeffrey | Composition comprising combination of rapamycin and an activator of AMP kinase and use thereof for treating diseases |
CN105663027B (zh) * | 2016-04-01 | 2018-12-18 | 中国人民解放军广州军区武汉总医院 | 西罗莫司外用制剂、其制备方法及用途 |
CN109069418A (zh) * | 2016-04-04 | 2018-12-21 | 药品配送方案有限公司 | 包含他克莫司的局部组合物 |
IL267869B2 (en) | 2017-01-06 | 2023-10-01 | Palvella Therapeutics Inc | Non-aqueous preparations of mTOR inhibitors and methods of use |
KR101973065B1 (ko) | 2017-09-13 | 2019-04-26 | (주)썬테크 | 풍력 발전기 및 풍력 발전기의 블레이드 팁 |
EP3542788A1 (en) | 2018-03-19 | 2019-09-25 | MC2 Therapeutics Limited | Topical composition comprising calcipotriol and betamethasone dipropionate |
KR101995905B1 (ko) | 2018-03-27 | 2019-07-04 | (주)썬테크 | 풍력 발전기 및 풍력 발전기의 발전모터 |
WO2019233722A1 (en) * | 2018-06-08 | 2019-12-12 | Almirall, S.A. | Pharmaceutical composition comprising tacrolimus |
WO2020010073A1 (en) | 2018-07-02 | 2020-01-09 | Palvella Therapeutics, Inc. | ANHYDROUS COMPOSITIONS OF mTOR INHIBITORS AND METHODS OF USE |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4299826A (en) | 1979-10-12 | 1981-11-10 | The Procter & Gamble Company | Anti-acne composition |
US4894366A (en) | 1984-12-03 | 1990-01-16 | Fujisawa Pharmaceutical Company, Ltd. | Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same |
PH26083A (en) | 1987-11-09 | 1992-02-06 | Sandoz Ltd | 11, 28-dioxa-4-azatricyclo [22.3.1.04.9) octacos-18-ene derivatives and pharmaceutical compositions containing them and method of use thereof |
JP2799208B2 (ja) | 1987-12-09 | 1998-09-17 | フアイソンズ・ピーエルシー | マクロ環状化合物 |
KR0159766B1 (ko) * | 1989-10-16 | 1998-12-01 | 후지사와 토모키치로 | 양모제 조성물 |
NZ235991A (en) * | 1989-11-09 | 1993-05-26 | Sandoz Ltd | Macrolide compounds and pharmaceutical compositions thereof |
US5061700A (en) | 1989-11-16 | 1991-10-29 | Gordon Jay Dow | Glyceryl acetate ointment vehicles |
JPH05504956A (ja) | 1990-03-12 | 1993-07-29 | 藤沢薬品工業株式会社 | トリシクロ化合物 |
EP0533930A1 (en) | 1990-06-11 | 1993-03-31 | Fujisawa Pharmaceutical Co., Ltd. | Use of a macrolide compound such as fk 506 for manufacturing a medicament for treating idiopathic thrombocytopenic purpura and basedow's disease |
MY110418A (en) | 1990-07-02 | 1998-05-30 | Novartis Ag | Heteroatoms-containing tricyclic compounds. |
ATE150304T1 (de) * | 1990-09-04 | 1997-04-15 | Fujisawa Pharmaceutical Co | Tricyclische verbindungen enthaltende salben |
US5143918A (en) * | 1990-10-11 | 1992-09-01 | Merck & Co., Inc. | Halomacrolides and derivatives having immunosuppressive activity |
PH31204A (en) * | 1990-11-02 | 1998-05-05 | Fujisawa Pharmaceutical Co | Pharmaceutical composition. |
CA2054983A1 (en) | 1990-11-08 | 1992-05-09 | Sotoo Asakura | Suspendible composition and process for preparing the same |
US5252732A (en) | 1991-09-09 | 1993-10-12 | Merck & Co., Inc. | D-heteroaryl, O-alkylheteroaryl, O-alkenylheteroaryl and O-alkynylheteroarylmacrolides having immunosuppressive activity |
US5208241A (en) | 1991-09-09 | 1993-05-04 | Merck & Co., Inc. | N-heteroaryl, n-alkylheteroaryl, n-alkenylheteroaryl and n-alkynylheteroarylmacrolides having immunosuppressive activity |
US5247076A (en) | 1991-09-09 | 1993-09-21 | Merck & Co., Inc. | Imidazolidyl macrolides having immunosuppressive activity |
HUT66531A (en) | 1992-05-07 | 1994-12-28 | Sandoz Ag | Heteroatoms-containing tricyclic compounds, pharmaceutical prepns contg. them and process for producing them |
GB9221220D0 (en) * | 1992-10-09 | 1992-11-25 | Sandoz Ag | Organic componds |
JPH06183970A (ja) * | 1992-12-16 | 1994-07-05 | Fujisawa Pharmaceut Co Ltd | 医薬用組成物 |
CH686761A5 (de) * | 1993-05-27 | 1996-06-28 | Sandoz Ag | Galenische Formulierungen. |
MY110603A (en) | 1993-05-27 | 1998-08-29 | Novartis Ag | Tetrahydropyran derivatives |
DE10199039I2 (de) | 1993-10-22 | 2008-08-07 | Hexal Ag Ind 25 | Pharmazeutische zusammensetzung mit cyclosporin a, einen vitamin e derivat und einen emulgator |
-
1995
- 1995-10-26 PL PL95319599A patent/PL184750B1/pl unknown
- 1995-10-26 DK DK01117396T patent/DK1147766T3/da active
- 1995-10-26 EP EP95936554A patent/EP0786986B1/en not_active Expired - Lifetime
- 1995-10-26 HU HU9701928A patent/HU223840B1/hu active IP Right Revival
- 1995-10-26 BR BR9509530A patent/BR9509530A/pt not_active Application Discontinuation
- 1995-10-26 NZ NZ295170A patent/NZ295170A/xx not_active IP Right Cessation
- 1995-10-26 CZ CZ19971232A patent/CZ289773B6/cs not_active IP Right Cessation
- 1995-10-26 AT AT95936554T patent/ATE214593T1/de active
- 1995-10-26 ES ES01117396T patent/ES2243369T3/es not_active Expired - Lifetime
- 1995-10-26 WO PCT/EP1995/004208 patent/WO1996013249A1/en active IP Right Grant
- 1995-10-26 CA CA002200966A patent/CA2200966C/en not_active Expired - Lifetime
- 1995-10-26 SK SK520-97A patent/SK284591B6/sk not_active IP Right Cessation
- 1995-10-26 MX MX9702699A patent/MX9702699A/es active IP Right Grant
- 1995-10-26 NZ NZ331824A patent/NZ331824A/xx not_active IP Right Cessation
- 1995-10-26 CN CN95195900A patent/CN1089233C/zh not_active Expired - Lifetime
- 1995-10-26 PT PT95936554T patent/PT786986E/pt unknown
- 1995-10-26 DE DE69525957T patent/DE69525957T2/de not_active Expired - Lifetime
- 1995-10-26 SI SI9530589T patent/SI0786986T1/xx unknown
- 1995-10-26 ES ES95936554T patent/ES2173978T3/es not_active Expired - Lifetime
- 1995-10-26 PT PT01117396T patent/PT1147766E/pt unknown
- 1995-10-26 EP EP01117396A patent/EP1147766B1/en not_active Expired - Lifetime
- 1995-10-26 DK DK95936554T patent/DK0786986T3/da active
- 1995-10-26 AT AT01117396T patent/ATE299017T1/de active
- 1995-10-26 DE DE19581804T patent/DE19581804T1/de not_active Ceased
- 1995-10-26 JP JP51431096A patent/JP4155593B2/ja not_active Expired - Lifetime
- 1995-10-26 DE DE69534306T patent/DE69534306T2/de not_active Expired - Lifetime
- 1995-10-26 CN CNB021243700A patent/CN100335063C/zh not_active Expired - Lifetime
- 1995-10-26 KR KR1019970702752A patent/KR100434682B1/ko not_active IP Right Cessation
- 1995-10-26 AU AU38451/95A patent/AU714254B2/en not_active Expired
- 1995-10-26 GB GB9707484A patent/GB2308546B/en not_active Expired - Lifetime
-
1997
- 1997-03-11 FI FI971018A patent/FI119754B/fi not_active IP Right Cessation
- 1997-04-25 NO NO19971951A patent/NO316963B1/no not_active IP Right Cessation
-
2000
- 2000-12-01 CY CY0000067A patent/CY2211B1/xx unknown
-
2001
- 2001-01-23 US US09/767,656 patent/US6352998B2/en not_active Expired - Lifetime
-
2003
- 2003-08-20 HK HK03105954A patent/HK1053611A1/xx not_active IP Right Cessation
-
2004
- 2004-09-08 NO NO2004005C patent/NO2004005I2/no unknown
-
2007
- 2007-02-27 JP JP2007047216A patent/JP2007145860A/ja not_active Withdrawn
- 2007-12-28 FI FI20071025A patent/FI119755B/fi not_active IP Right Cessation
-
2012
- 2012-03-29 JP JP2012077545A patent/JP5599422B2/ja not_active Expired - Lifetime
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2012131827A5 (ja) | ||
JP2008513467A5 (ja) | ||
CA2894892A1 (en) | Boronic acid derivatives and therapeutic uses thereof | |
JP2014129360A5 (ja) | ||
BR112015012547A2 (pt) | composições de prostaciclina e métodos de sua utilização | |
MX2015006632A (es) | Formulaciones de uso topico de tetraciclina, preparaciones y usos de las mismas. | |
JP2014218522A5 (ja) | ||
JP2016510019A5 (ja) | ||
BR112015000229A2 (pt) | formulações aquosas estáveis de etanercept | |
BR112014014832A2 (pt) | formulação e método de controlar fungos | |
WO2014108846A3 (en) | Soothing cosmetic composition based on salicylic acid | |
JP2013538853A5 (ja) | ||
TR201818761T4 (tr) | 4-amino-5-floro-3-[6-(4-metilpiperazin-1-il)-1h-benzimidazol-2-il]-1h-kinolin-2-on laktat monohidrat içeren farmasötik bileşimler. | |
AR091039A1 (es) | Composiciones farmaceuticas topicas que comprenden terbinafina, uso y metodo de tratamiento | |
JP2012236016A5 (ja) | ||
RS53783B1 (en) | INHALATION MEDICINAL PRODUCTS INCLUDING TIOTROPIUM | |
RS54131B1 (en) | NEW PHARMACEUTICAL FORMULATION FOR FUNGAL INFECTION TREATMENT | |
FR2999086B1 (fr) | Composition orale et/ou buccale sous forme de film fin d'un principe actif faiblement soluble, son procede de preparation et son utilisation | |
JP2014062109A5 (ja) | ||
JP2013253067A5 (ja) | ||
RU2016138028A (ru) | Жидкие фармацевтические суспензии, содержащие висмут | |
JP2016534062A5 (ja) | ||
BR112015027436A8 (pt) | composição tópica e veículo para administração de ingredientes farmaceuticamente ou cosmeticamente ativos | |
FR2999934B1 (fr) | Composition pharmaceutique sous la forme d'une suspension orale comprenant une fraction flavonoique et de la gomme xanthane | |
CO7101241A2 (es) | Formulaciones de antibióticos |